-
Featured Authors
-
Archives
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIO
Our commitments to help heal, fuel and feed the world
By Stephen Sherwin, Former Chairman of BIO All of us who have chosen careers in biotech began our journey because we passionately believe in the ability of our industry to improve the human condition. For many of us, this means devoting our career to improving the treatment of incurable diseases. For others, this means employing the power of biotech to provide high-quality and healthy food for everyone on this planet. And, for still others it Read More >
Bioenergy Business Outlook Survey Shows Bullish Market Expectations
Encouraged by the continued demand for alternative fuels, bioenergy executives are optimistic that their industry will be an increasingly investment-driven enterprise, according to the findings of the Summer 2011 Bioenergy Business Outlook survey. The quarterly survey, co-sponsored by Biofuels Digest and BIO, was discussed at the BIO International Convention today by Jim Lane, editor of Biofuels Digest; Brent Erickson, Executive Vice President, BIO; and Adam Monroe, President, Novozymes North America. The survey reflects expectations for Read More >
Biotech Patenting and Tech Transfer at 2011 BIO International Convention
The Biotech Patenting and Tech Transfer track has a lot to offer 2011 BIO International Convention Attendees. High level speakers include White House Intellectual Property Enforcement Coordinator Victoria Espinel, European Patent Office Director of Biotechnology Sjoerd Hoekstra, retired Chief Judge of the U.S. Court of Appeals for the Federal Circuit Paul Michel, and former Solicitors General Seth Waxman and Paul Clement to name a few. I am particularly excited about the breadth of the Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: 2011 BIO International Convention, BIO, biosimilars, Biotech Patenting, collaboration, Collaborative R&D, Compulsory Licensing, Counterfeiting, EPO, Myriad Case, Patent Linkage, Patents in the Supreme Court, Paul Clement, Paul Michel, Seth Waxman, Sjoerd Hoekstra, Tech Transfer, Technology Transfer, Victoria Espinel
Tags: 2011 BIO International Convention, BIO, biosimilars, Biotech Patenting, collaboration, Collaborative R&D, Compulsory Licensing, Counterfeiting, EPO, Myriad Case, Patent Linkage, Patents in the Supreme Court, Paul Clement, Paul Michel, Seth Waxman, Sjoerd Hoekstra, Tech Transfer, Technology Transfer, Victoria Espinel
House Patent Reform Bill, HR 1249, still has the Administration’s and BIO’s support
The White House, Office of Management and Budget, Office of Science and Technology Policy, and the United States Patent and Trademark Office have come out in support of HR 1249 and the Manager’s Amendment to the bill. The only caveat mentioned is that “final legislative action [should] ensure that the US Patent and Trademark Office’s (USPTO’s) fee collections are made fully available to support the nation’s patent and trademark system.” BIO also has come out in Read More >
Translational Research Forum at BIO International Convention
BIO is hosting a Translation Research Forum at the BIO International Convention. NIH Director Collins keynotes an event that will explore how private, public and academic sectors can leverage meaningful partnerships, highlight emerging best practices, explore risk-sharing at the clinical research stage, and explore ways to bridge the gap in funding and know-how necessary to take university research to the next level. Read the Press Release for more information about panels and speakers. For registration, conference Read More >
